Spero Therapeutics – Metaverse Startup
Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections.
Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections. The company leverages a top-tier chemistry and microbiology team, an efficient virtual approach to drug development, and a focus on high potential, novel mechanisms to fill the unmet need for early stage therapeutics targeting serious bacterial infections. Spero’s lead program addresses a novel target driving virulence and persistence of Pseudomonas Aeruginosa infections and other Gram-negative pathogens. The company was founded by Atlas Venture, with financing from SR One and the Partners Innovation Fund.
Learn more about this company on Crunchbase.
Own or work here?
Claim Now!
Claim Now!
